New Managing Director of the technology division

Dr. Christoph Petry took over as head of the company’s technology development.

Dr. Petry will direct the broadening of m2p-labs’ commercial product and service offer through the introduction of new microbioreactors products for diversified applications.

Starting on October 1st, Dr. Christoph Petry took over as head of the company’s technology development. With over 20 years of experience in the health care sector, and as founder and CEO of a start-up company, he will focus on the continuous improvement of m2p-labs core products.

Over the longer term, Dr. Petry will direct the broadening of m2p-labs’ commercial product and service offer through the introduction of new microbioreactors products for diversified applications. At the same time, two further new colleagues have joined the company “I am happy to welcome Mark Friesen and John Wetzel to our engineering department.” said Dr. Petry. “With this enthusiastic team, we are confident that we will continue to serve our customers with excellent microbioreactor solutions”.